ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 84 filers reported holding ARALEZ PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 3.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $7,000 | +75.0% | 4,916 | +251.1% | 0.00% | – |
| Q3 2017 | $4,000 | +300.0% | 1,400 | +366.7% | 0.00% | – |
| Q2 2017 | $1,000 | -97.9% | 300 | -98.6% | 0.00% | -100.0% |
| Q1 2017 | $47,000 | +571.4% | 21,876 | +1721.5% | 0.01% | +400.0% |
| Q4 2016 | $7,000 | -41.7% | 1,201 | -51.9% | 0.00% | 0.0% |
| Q3 2016 | $12,000 | -74.5% | 2,499 | -82.6% | 0.00% | -75.0% |
| Q2 2016 | $47,000 | – | 14,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 289,664 | $434,000 | 0.43% |
| SALZHAUER MICHAEL | 220,153 | $330,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,644,583 | $2,467,000 | 0.08% |
| Brown Advisory Securities, LLC | 272,000 | $408,000 | 0.08% |
| Par Capital Management | 4,431,301 | $6,647,000 | 0.07% |
| ISTHMUS PARTNERS, LLC | 176,170 | $264,000 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 96,429 | $145,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 262,544 | $394,000 | 0.02% |
| Ballentine Partners, LLC | 100,000 | $150,000 | 0.01% |
| NWAM LLC | 20,000 | $30,000 | 0.01% |